Welcome to PsychU!

Focus On Primary Care: Lessons On Mental Health One Year After The Pandemic

On March 11, 2020, the World Health Organization declared COVID-19 a global pandemic. In the year since, the world has experienced the effects of the virus directly through infection and indirectly through changes to social and economic life including a rise in mental health needs. Jason Carter, PharmD, Senior Medical Liaison interviews our Section Advisors, Brendan Montano, MD and Clay Jackson, MD on the mental health impact of the pandemic one year later. Below are resources for patients and primary care providers on this important issue.

Featuring:

  • Brendan Montano, MD
    Director and Principal Investigator, Connecticut Clinical Research, PsychU Primary Care Provider Corner Advisor
  • Clay Jackson, MD
    Clinical Assistant Professor of Family Medicine and Psychiatry, University of Tennessee College of Medicine, PsychU Primary Care Provider Corner Advisor
  • Jason Carter, PharmD
    Senior Medical Liaison, Otsuka Pharmaceutical Development & Commercialization, Inc.

PsychU’s Patient Education Materials
COVID-19 and Your Mental Health

Other Resources for Patients
Center for Disease Control’s (CDC) Coping with Stress during the Pandemic
National Alliance for Mental Illnesses’ (NAMI)  COVID-19 Resource Guide

Additional Information is available through PsychU’s Webinars
Day in the Life of Primary Care during the Pandemic
The Impact of Pandemics on Well-Being: Implications for Healthcare Systems & Providers
The Global Impact of the Novel Coronavirus Pandemic on Mental Health & Suicide
Psychiatry Perspectives on Patient Care in a Post-Pandemic World
Managing Mental Health During & In the Aftermath of a Pandemic

Resources for Primary Care Providers
American Medical Association’s Managing Mental Health During COVID-19

Brendan Montano, MD and Clay Jackson, MD are compensated consultants of Otsuka Pharmaceutical Development & Commercialization, Inc.
Jason Carter, PharmD, is an employee of Otsuka Pharmaceutical Development & Commercialization, Inc.

Disclaimer: PsychU is supported by Otsuka Pharmaceutical Development & Commercialization, Inc. (OPDC) and Otsuka America Pharmaceutical, Inc. (OAPI). Specific PsychU programs may be supported by OPDC, OAPI and other committed supporters of the mental health treatment community. The opinions expressed by PsychU’s contributors are their own and are not endorsed or recommended by PsychU or its sponsor or the sponsors of the specific PsychU program in which such opinions are expressed. The information provided through PsychU is intended for the educational benefit of mental health care professionals and others who support mental health care. It is not intended as, nor is it a substitute for, medical care, advice, or professional diagnosis. Health care professionals should use their independent medical judgement when reviewing PsychU’s educational resources. Users seeking medical advice should consult with a health care professional. No CME or CEU credits are available through any of the resources provided by PsychU. Some of the contributors may be paid consultants for OPDC and OAPI.

US.CORP.X.21.00078 / US.CORP.V.21.00021